ELIZA SABO: Open Payments
NPI 1174363238 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 81 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $365 |
| Axsome Therapeutics, Inc. | 11 | $179 |
| Alkermes, Inc. | 5 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| Braeburn Inc. | 5 | $93 |
| Indivior Inc. | 3 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Almatica Pharma LLC | 2 | $43 |
| Noven Therapeutics, LLC | 2 | $33 |
| Corium, LLC | 2 | $31 |
Products named: VRAYLAR, Auvelity, CAPLYTA, BRIXADI, SUBLOCADE, LYBALVI, VIVITROL, FANAPT.
Industry payments across AZ — which companies pay providers there.
